关于在血管化中开发治疗方法的考虑
Ana M Valentin Cabrera1, Sophie K Ashbrook1, Joshua D Hutcheson1
1Department of Biomedical Engineering, Florida International University, Miami, FL 33174, USA.
Journal of cardiovascular development and disease
|June 25, 2025
概括
血管化是心血管疾病死亡率的关键预测因素,涉及动脉中的沉积. 了解其机制和形态学对于开发有效的血管化疗法至关重要.
科学领域:
- 心血管医学 心血管医学
- 生物矿物化 生物矿物化
- 血管生物学 血管生物学
背景情况:
- 心血管疾病是全球主要的死亡原因.
- 血管化,动脉中的矿物沉积,显著预测了发病率和死亡率.
- 它以中间或内侧化形式发生,具有明显的关联 (例如,CKD,动脉样硬化).
研究的目的:
- 审查血管化机制.
- 研究导致沉积在动脉壁中的过程.
- 确定开发针对血管化的治疗方法的考虑因素.
主要方法:
- 关于血管化的文献评论.
- 细胞机制的分析,特别是光滑肌肉细胞的骨质分化.
- 检查矿物质形态和在血管化中的位置.
主要成果:
- 血管光滑肌细胞分化为骨质细胞,导致矿物沉积和动脉硬化.
- 中部化在慢性病中很常见;内部化与动脉样硬化和炎症有关.
- 血管化对心血管健康的影响取决于矿物质的特性.
结论:
- 血管化是一个复杂的过程,对健康有重大影响.
- 对机制和治疗策略的进一步研究是有必要的.
- 针对血管化,有可能减少心血管疾病和死亡率.
相关概念视频
Atherosclerosis III: Management
42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
Venous Thrombosis III: Interprofessional Care
28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28
Peripheral Artery Disease III: Interprofessional Care
34
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
34
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
706
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
706
Coronary Artery Disease V: Interprofessional Care
39
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
39
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
129
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
129


